186 related articles for article (PubMed ID: 19998046)
21. [Prevention and therapy of radiodermatitis in postoperative radiotherapy following mastectomy].
Kastratović M; Rödl W
Fortschr Med; 1971 Aug; 89(22):889-90. PubMed ID: 5154177
[No Abstract] [Full Text] [Related]
22. Prophylactically applied Hydrofilm polyurethane film dressings reduce radiation dermatitis in adjuvant radiation therapy of breast cancer patients.
Schmeel LC; Koch D; Stumpf S; Leitzen C; Simon B; Schüller H; Vornholt S; Schoroth F; Müdder T; Röhner F; Garbe S; Schmeel FC; Schild HH; Wilhelm-Buchstab TM
Acta Oncol; 2018 Jul; 57(7):908-915. PubMed ID: 29463159
[TBL] [Abstract][Full Text] [Related]
23. The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: a double-blind, randomized trial.
Kneebone A; Mameghan H; Bolin T; Berry M; Turner S; Kearsley J; Graham P; Fisher R; Delaney G
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):628-35. PubMed ID: 11597802
[TBL] [Abstract][Full Text] [Related]
24. [Multicenter double-blind clinical trial comparing sucralfate vs placebo in the prevention of diarrhea secondary to pelvic irradiation].
Valls A; Pestchen I; Prats C; Pera J; Aragón G; Vidarte M; Algara M
Med Clin (Barc); 1999 Nov; 113(18):681-4. PubMed ID: 10650568
[TBL] [Abstract][Full Text] [Related]
25. Prevention of irradiation-induced bowel discomfort by sucralfate: a double-blind, placebo-controlled study when treating localized pelvic cancer.
Henriksson R; Franzén L; Littbrand B
Am J Med; 1991 Aug; 91(2A):151S-157S. PubMed ID: 1882903
[TBL] [Abstract][Full Text] [Related]
26. The effect of vitamin E on acute skin reaction caused by radiotherapy.
Dirier A; Akmansu M; Bora H; Gurer M
Clin Exp Dermatol; 2007 Sep; 32(5):571-3. PubMed ID: 17535282
[TBL] [Abstract][Full Text] [Related]
27. Randomized Double-blind Placebo-controlled Trial of Celecoxib for the Prevention of Skin Toxicity in Patients Receiving Radiation Therapy for Breast Cancer.
Ghasemi A; Danesh B; Yazdani-Charati J; Hosseinimehr SJ
Antiinflamm Antiallergy Agents Med Chem; 2018; 17(1):57-67. PubMed ID: 29651970
[TBL] [Abstract][Full Text] [Related]
28. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
29. Skin-sparing intensity-modulated radiotherapy of the breast.
Vordermark D
J Clin Oncol; 2008 Jul; 26(19):3292; author reply 3292-3. PubMed ID: 18591570
[No Abstract] [Full Text] [Related]
30. [Acute skin toxicity in breast intensity modulated radiotherapy using field in field technique].
Blanchecotte J; Ruffier-Loubière A; Reynaud-Bougnoux A; Barillot I
Cancer Radiother; 2015 Apr; 19(2):82-8. PubMed ID: 25623257
[TBL] [Abstract][Full Text] [Related]
31. Novel measurements for radiodermatitis research and clinical care: A pilot and feasibility study.
Beamer LC
Eur J Oncol Nurs; 2019 Apr; 39():62-69. PubMed ID: 30850140
[TBL] [Abstract][Full Text] [Related]
32. Preventing Radiation-Induced Injury by Topical Application of an Amifostine Metabolite-Loaded Thermogel.
Clémenson C; Liu W; Bricout D; Soyez-Herkert L; Chargari C; Mondini M; Haddad R; Wang-Zhang X; Benel L; Bloy C; Deutsch E
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1141-1152. PubMed ID: 31063799
[TBL] [Abstract][Full Text] [Related]
33. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.
Ghasemi A; Ghashghai Z; Akbari J; Yazdani-Charati J; Salehifar E; Hosseinimehr SJ
Eur J Clin Pharmacol; 2019 Feb; 75(2):171-178. PubMed ID: 30291370
[TBL] [Abstract][Full Text] [Related]
34. [The use of sucralfate in radiation oncology].
Belka C; Hoffmann W; Paulsen F; Barnberg M
Strahlenther Onkol; 1997 May; 173(5):247-52. PubMed ID: 9198905
[TBL] [Abstract][Full Text] [Related]
35. Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis.
Rollmann DC; Novotny PJ; Petersen IA; Garces YI; Bauer HJ; Yan ES; Wahner-Roedler D; Vincent A; Sloan JA; Issa Laack NN
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):650-8. PubMed ID: 25936812
[TBL] [Abstract][Full Text] [Related]
36. Effects of Boron-Based Gel on Radiation-Induced Dermatitis in Breast Cancer: A Double-Blind, Placebo-Controlled Trial.
Aysan E; Idiz UO; Elmas L; Saglam EK; Akgun Z; Yucel SB
J Invest Surg; 2017 Jun; 30(3):187-192. PubMed ID: 27700210
[TBL] [Abstract][Full Text] [Related]
37. Significant suppression of radiation dermatitis in breast cancer patients using a topically applied adrenergic vasoconstrictor.
Cleary JF; Anderson BM; Eickhoff JC; Khuntia D; Fahl WE
Radiat Oncol; 2017 Dec; 12(1):201. PubMed ID: 29273054
[TBL] [Abstract][Full Text] [Related]
38. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
[TBL] [Abstract][Full Text] [Related]
39. Smoking as an independent risk factor for severe skin reactions due to adjuvant radiotherapy for breast cancer.
Sharp L; Johansson H; Hatschek T; Bergenmar M
Breast; 2013 Oct; 22(5):634-8. PubMed ID: 23953136
[TBL] [Abstract][Full Text] [Related]
40. Measurement of breast skin viscoelasticity and a pilot study on the potential radioprotective effect of a zinc-based cream.
Gorodetsky R; Andriessen A; Polyansky I; Vexler A
J Wound Care; 1999 Nov; 8(10):514-8. PubMed ID: 10827657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]